World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
50
Citations
6727
World Ranking
17786
National Ranking
161

Overview

Gerald Brosch is affiliated with Innsbruck Medical University in Austria and has contributed research primarily in the fields of Biochemistry, Genetics and Molecular Biology as well as Medicine. Their work spans multiple subfields including Molecular Biology, Oncology, and Pharmacology.

Their research focuses extensively on topics related to Histone Deacetylase Inhibitors, Protein Degradation and Inhibitors, and Epigenetics and DNA Methylation. Other notable areas covered are Peptidase Inhibition and Analysis, and fungal biology, particularly fungal and yeast genetics and applications.

Notable recent publications include:

  • A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation, 2022, PLoS Genetics
  • Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity, 2020, ChemMedChem
  • RcLS2F - A Novel Fungal Class 1 KDAC Co-repressor Complex in Aspergillus nidulans, 2020, Frontiers in Microbiology

Gerald Brosch frequently collaborates with several researchers, including Lena Hess, Verena Moos, Arnel A. Lauber, Wolfgang Reiter, and Michael Schuster. Collaboration with these coauthors is evident across different projects and publications.

Publication venues where Gerald Brosch's work has appeared include:

  • PLoS Genetics
  • ChemMedChem
  • Frontiers in Microbiology

Best Publications

  • Histone deacetylase 1 can repress transcription by binding to Sp1.

    Angelika Doetzlhofer;Hans Rotheneder;Gerda Lagger;Manfred Koranda

  • Inhibition of maize histone deacetylases by HC toxin, the host-selective toxin of Cochliobolus carbonum.

    Gerald Brosch;Richard Ransom;Thomas Lechner;Jonathan D. Walton

  • Identification of Maize Histone Deacetylase HD2 as an Acidic Nucleolar Phosphoprotein

    Alexandra Lusser;Gerald Brosch;Adele Loidl;Hubertus Haas

  • Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas

    Keith W. Vance;Suzanne Carreira;Gerald Brosch;Colin R. Goding

  • Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation.

    Manfred Jung;Gerald Brosch;Doris Kölle;Hans Scherf

  • Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides.

    Antonello Mai;Silvio Massa;Riccardo Pezzi;Silvia Simeoni

  • Histone modifications and chromatin dynamics: a focus on filamentous fungi

    Gerald Brosch;Peter Loidl;Stefan Graessle

  • Target-Based Approach to Inhibitors of Histone Arginine Methyltransferases

    Astrid Spannhoff;Ralf Heinke;Ingo Bauer;Patrick Trojer

  • 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking procedures

    Antonello Mai;Silvio Massa;Rino Ragno;Ilaria Cerbara

  • epigenetic multiple ligands: mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors.

    Antonello Mai;Donghang Cheng;Mark T. Bedford;Sergio Valente

  • Biochemical methods for analysis of histone deacetylases.

    Doris Kölle;Gerald Brosch;Thomas Lechner;Alexandra Lusser

  • Analogues of trichosтatin a and trapoxin B as histone deacetylase inhibitors

    Manfred Jung;Katharina Hoffmann;Gerald Brosch;Peter Loidl

  • A non-isotopic assay for histone deacetylase activity

    Katharina Hoffmann;Manfred Jung;Gerald Brosch;Peter Loidl

  • Small molecule inhibitors of histone arginine methyltransferases: homology modeling, molecular docking, binding mode analysis, and biological evaluations.

    Rino Ragno;Silvia Simeoni;Sabrina Castellano;Caterina Vicidomini

  • 1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells.

    Sergio Valente;Daniela Trisciuoglio;Teresa De Luca;Angela Nebbioso

  • 3-(4-aroyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides, a new class of synthetic histone deacetylase inhibitors.

    Silvio Massa;Antonello Mai;Gianluca Sbardella;Monica Esposito

  • Sds3 (Suppressor of Defective Silencing 3) Is an Integral Component of the Yeast Sin3·Rpd3 Histone Deacetylase Complex and Is Required for Histone Deacetylase Activity *

    Thomas Lechner;Michael J. Carrozza;Yaxin Yu;Patrick A. Grant

  • Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans.

    Antonello Mai;Dante Rotili;Silvio Massa;Gerald Brosch

  • A novel arginine methyltransferase inhibitor with cellular activity.

    Astrid Spannhoff;Rospita Machmur;Ralf Heinke;Patrick Trojer

  • Histone deacetylase. A key enzyme for the binding of regulatory proteins to chromatin.

    Gerardo López-Rodas;Gerald Brosch;Elena I. Georgieva;Elena I. Georgieva;Ramón Sendra;Ramón Sendra

Frequent Co-Authors

Peter Loidl
Peter Loidl Innsbruck Medical University
Antonello Mai
Antonello Mai Sapienza University of Rome
Lucia Altucci
Lucia Altucci University of Campania "Luigi Vanvitelli"
Sergio Valente
Sergio Valente Sapienza University of Rome
Dante Rotili
Dante Rotili Sapienza University of Rome
Hubertus Haas
Hubertus Haas Innsbruck Medical University
Manfred Jung
Manfred Jung University of Freiburg
Jonathan D. Walton
Jonathan D. Walton Michigan State University
Christian Seiser
Christian Seiser Medical University of Vienna
Herbert Lindner
Herbert Lindner Innsbruck Medical University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Gerald Brosch

Trending Scientists

Recently Published Articles